Transgender youth on gender-affirming hormone therapy have differences in their percent fat and lean mass compared with cisgender youth.
The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.
Increased risk for heart failure also seen in group of participants without diastolic dysfunction
Lp(a) is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease for patients with type 1 diabetes.
Suboptimal diet accounts for 18.2 percent of all cardiometabolic disease costs in the United States.
A greater quantity of oral nitrate-reducing bacteria was found to be associated with reduced plasma glucose and insulin resistance in young to middle-aged adults.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Adverse cardiometabolic outcomes were more commonly observed among patients from black and ethnic minority groups compared with white patients.
Associations were established between recovery from and development of metabolic syndrome and reduced and elevated risk for major adverse cardiovascular events, respectively.
Racial differences in disease expression and adverse clinical outcomes exist between black and white patients with hypertrophic cardiomyopathy.
In patients with acute coronary syndrome, the early in-hospital addition of evolocumab to high-dose statin therapy was found to be safe, well tolerated, and efficacious in reducing low-density lipoprotein cholesterol levels.
Want to read more?
Please login or register first to view this content.
Next post in Metabolic